Related Experiment Videos
[A clinical study of PC-904 in pediatric field (author's transl)]
Insights
This clinical study found PC-904 antibiotic effective in 46.2% of pediatric patients with infections like urinary tract infections. While generally safe, it is recommended as a second-choice treatment.
Area of Science:
- Pediatric infectious diseases
- Clinical pharmacology
- Antibiotic efficacy
Context:
- PC-904 is an intravenously administered antibiotic.
- A clinical trial was conducted to evaluate its efficacy and safety in pediatric patients.
- The study included children diagnosed with various infections.
Purpose:
- To assess the efficacy of PC-904 in treating pediatric infections.
- To evaluate the safety and adverse reactions associated with PC-904 administration.
- To determine the appropriate clinical பயன்பாடு (usage) of PC-904.
Summary:
- PC-904 was administered intravenously to 13 children at daily dosages of 20-120 mg/kg for conditions including urinary tract infection, acute pneumonia, sepsis, and purulent meningitis.
- The overall efficacy rate was 46.2%.
- Adverse reactions were minimal, with eosinophilia observed in only 2 patients. No side effects were noted in a single neonate treated.
Impact:
- PC-904 demonstrated a 46.2% efficacy rate in pediatric patients with serious infections.
- The antibiotic was found to be generally safe with a low incidence of adverse effects.
- PC-904 is considered a potentially useful second-choice antibiotic for pediatric infections, rather than a first-line treatment.
Abstract:
A clinical study of PC-904 was performed and the following results were obtained. 1) PC-904 was intravenously administered at the daily dosage of 20 approximately 120 mg/kg to 13 children; urinary tract infection (10 cases), acute pneumonia (1 case), sepsis (1 case) and purulent meningitis (1 case). The overall efficacy rate was 46.2%. 2) As to adverse reaction, eosinophilia was noted only in 2 patients. One neonate was treated with this drug, but no side effects were observed. 3) It was considered that PC-904 was a useful antibiotic drug for the second choice rather than the first.